The FDA authorized a second booster dose of either the Pfizer or Moderna COVID-19 vaccines for individuals aged 50 and older at least four months after their first booster dose, and for immunocompromised individuals at least four months after their first booster dose. Immunocompromised individuals include those who have undergone solid organ transplants or those living with conditions considered to have an equivalent level of immunocompromise.
